NOTE: ALL NEWS REPORTS ARE EMBARGOED UNTIL DATE AND TIME OF PRESENTATION
TUESDAY, September 10, 2013
Keynote Lecture: Rethinking Disease
The reductionist attitude of classic antibacterial therapy, crystallized in the dominant "culture of monotherapy" has contributed to perversely fix the old perception of "one disease-one pathogen-one drug". Bacterial diseases are always the result of a complex array of pathogenic factors. This session will address the multifaceted and integrated therapeutic interventions aiming to restore the health of all sick compartments involved in infection.
Fernando Baquero, Ramn y Cajal Inst. for Hlth. Res., Madrid, Spain
Keynote Session 1
Chemotherapy, Diarrhea and the Intestinal Microbiome
Researchers have identified changes to the microbiome that can indicate the potential onset of chemotherapy-induced diarrhea (CID) as early as 6 days before symptoms appear, a finding that could help identify patients at high risk for severe CID.
Emmanuel Montassier, Universit de Nantes, France
Poster Session 6, Paper B-030
Removal of Antibiotic Leads to Loss of Resistance
In the case of methicillin-resistant Staphylococcus aureus (MRSA) where the bacteria were resistant to the antibiotic linezolid due to the presence of the cfr gene, removal of the selective pressure of the antibiotic caused the bacteria to lose the gene and regain susceptibility.
Emilia Cercenado, Hosp. Gen. Univ.o Gregorio Maran, Madrid, Spain
Poster Session 11, Paper C2-077 (summary available)
New Generation Diagnostics Could Impact Therapy
A retrospective analysis of bloodstream infections in the United Kingdom suggests that the use of a relatively new diagnostic system known as matrix-assisted laser desoption ionization time-of-flight mass spectrometry (MALDI-TOF MS)
|Contact: Garth Hogan|
American Society for Microbiology